Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation - PubMed (original) (raw)
. 2000 Dec;58(6):1412-23.
doi: 10.1124/mol.58.6.1412.
Affiliations
- PMID: 11093781
- DOI: 10.1124/mol.58.6.1412
Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation
D A Hall. Mol Pharmacol. 2000 Dec.
Abstract
Allosteric modulation is a mechanism for modifying pharmacological receptor activity that has largely been ignored in terms of therapeutic drug design, although benzodiazepine receptor ligands are an example of the serendipitous discovery of this class of compound. The current mathematical models of allosteric interactions at (particularly G-protein-coupled) receptors concentrate on the effects of the allosteric ligand on orthosteric ligand binding and ignore potential effects of these compounds on the ability of orthosteric ligands to cause receptor activation. In this report a mathematical model of allosteric interactions at pharmacological receptors has been investigated that explicitly includes effects of the allosteric ligand on receptor activation. This model uses the two-state model of receptor activation as its basis and is qualitatively consistent with currently reported behavior of allosteric modulators. The predictions of this model suggest a series of criteria that should be tested before the effects of an allosteric modulator can be quantified in a nonsystem-dependent manner. It has also been used to provide a potential mechanistic explanation for the functional effects of the A(1) adenosine receptor allosteric enhancer PD 81,723 and a recently reported allosteric modulator of type 1 metabotropic glutamate receptors.
Similar articles
- Integrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.
Bian Y, Feng Z, Yang P, Xie XQ. Bian Y, et al. AAPS J. 2017 Jul;19(4):1235-1248. doi: 10.1208/s12248-017-0093-5. Epub 2017 May 30. AAPS J. 2017. PMID: 28560482 Free PMC article. - Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.
Langmead CJ. Langmead CJ. J Biomol Screen. 2007 Aug;12(5):668-76. doi: 10.1177/1087057107301854. Epub 2007 May 3. J Biomol Screen. 2007. PMID: 17478477 - Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
Johnson MP, Nisenbaum ES, Large TH, Emkey R, Baez M, Kingston AE. Johnson MP, et al. Biochem Soc Trans. 2004 Nov;32(Pt 5):881-7. doi: 10.1042/BST0320881. Biochem Soc Trans. 2004. PMID: 15494040 Review. - Profiling of orthosteric and allosteric group-III metabotropic glutamate receptor ligands on various G protein-coupled receptors with Tag-lite® assays.
Belhocine A, Veglianese P, Hounsou C, Dupuis E, Acher F, Durroux T, Goudet C, Pin JP. Belhocine A, et al. Neuropharmacology. 2018 Sep 15;140:233-245. doi: 10.1016/j.neuropharm.2018.07.032. Epub 2018 Aug 9. Neuropharmacology. 2018. PMID: 30099051 - Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR, Thakur GA. Janero DR, et al. Expert Opin Drug Discov. 2016 Dec;11(12):1223-1237. doi: 10.1080/17460441.2016.1245289. Epub 2016 Oct 21. Expert Opin Drug Discov. 2016. PMID: 27712124 Free PMC article. Review.
Cited by
- Hybrid Allosteric Modulators of M1 Muscarinic Receptors Enhance Acetylcholine Efficacy and Decrease Locomotor Activity and Turning Behaviors in Zebrafish.
Widman CJ, Ventresca S, Dietrich J, Elmslie G, Smith H, Kaup G, Wesley A, Doenecke M, Williams FE, Schiefer IT, Ellis J, Messer WS. Widman CJ, et al. Res Sq [Preprint]. 2024 Feb 15:rs.3.rs-3901189. doi: 10.21203/rs.3.rs-3901189/v1. Res Sq. 2024. PMID: 38410427 Free PMC article. Updated. Preprint. - Scalable rule-based modelling of allosteric proteins and biochemical networks.
Ollivier JF, Shahrezaei V, Swain PS. Ollivier JF, et al. PLoS Comput Biol. 2010 Nov 4;6(11):e1000975. doi: 10.1371/journal.pcbi.1000975. PLoS Comput Biol. 2010. PMID: 21079669 Free PMC article. - Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.
Franco R. Franco R. J Neural Transm (Vienna). 2009 Aug;116(8):983-7. doi: 10.1007/s00702-008-0148-y. Epub 2008 Nov 11. J Neural Transm (Vienna). 2009. PMID: 19002553 Review. - Matching models to data: a receptor pharmacologist's guide.
Hall DA, Langmead CJ. Hall DA, et al. Br J Pharmacol. 2010 Nov;161(6):1276-90. doi: 10.1111/j.1476-5381.2010.00879.x. Br J Pharmacol. 2010. PMID: 20977467 Free PMC article. Review. - Quantitative analysis of aspartate receptor signaling complex reveals that the homogeneous two-state model is inadequate: development of a heterogeneous two-state model.
Bornhorst JA, Falke JJ. Bornhorst JA, et al. J Mol Biol. 2003 Mar 7;326(5):1597-614. doi: 10.1016/s0022-2836(03)00026-3. J Mol Biol. 2003. PMID: 12595268 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources